Abstract
Nerve-sparing radical prostatectomy is the therapy of choice in selected prostate
cancer patients. In an internal quality control including a questionnaire, our nerve-sparing
radical prostatectomies have been analysed for oncological and functional results
as well as patient satisfaction. 171 consecutive nerve sparing radical prostatectomies
have been analysed, 123 bilateral, 48 unilateral. The median follow-up was 26 (2–56)
months. The operations were performed by 5 surgeons. In 27 % the T-category and in
12 % the Gleason score had been understaged preoperatively, 9 % had positive margins
and in 4 % lymph nodes were positive. 99 % of the patients stated that they would
again prefer the operation as treatment of first choice. 95 % were satisfied with
their postoperative situation. 53 % of the patients had erections sufficient for sexual
intercourse following the bilateral, 25 % following the unilateral nerve-sparing procedure.
The time until recurrence of erections was 1 month in 42 %, 6 months in 90 % and 12 months
in 100 % of the potent men. 90 % of all patients within the observation period are
fully continent, 10 % of the patients need more than 1 pad. The intersurgeon variability
is 77–98 % for continence and 25–60 % for potency. Patient satisfaction, oncological
and functional results are good. The understaging rate suggests the necessity for
better patient selection including re-biopsy and reference histology. 27 % would
have been undertreated by brachytherapy as alternative treatment. Intensive surgeon
teaching is mandatory.
Key words
nerve-sparing radical prostatectomy - patient satisfaction - potency - continence
- influence of surgeon
References
1
Bannowsky A, Schulze H, van der Horst C et al.
Nocturnal tumescence: a parameter for postoperative erectile integrity after nerve
sparing radical prostatectomy.
J Urol.
2006;
175
2214-2217
2
Bianco Jr F J, Scardino P T, Eastham J A.
Radical prostatectomy: long-term cancer control and recovery of sexual and urinary
function (“trifecta”).
Urology.
2005;
66
83-94
3
Bill-Axelson A, Homberg L, Ruutu M Scandinavian prostate cancer group study No. 4
et al.,.
Radical prostatectomy versus watchful waiting in early prostate cancer.
NEJM.
2005;
352
1977-1984
4
Burkhard F C, Kessler T M, Fleischmann A et al.
Nerve sparing open radical retropubic prostatectomy-does it have an impact on urinary
continence?.
J Urol.
2006;
176
189-195
5
Burnett A L.
Erectile dysfunction following radical prostatectomy.
JAMA.
2005;
293
2648-2653
6
Catalona W J, Carvalhal G F, Mager D E et al.
Potency, continence an complication rates in 1870 consecutive radical retropubic prostatectomies.
J Urol.
1999;
162
433
7
Catalona W J, Ramos C G, Carvalhal G F.
Contemporary results of anatomic radical prostatectomy.
CA Cancer J Clin.
1999;
49
282
8
Han M, Partin A W, Chan D Y et al.
An evaluation of the decreasing incidence of positive surgical margins in al large
retropubic prostatectomy series.
J Urol.
2004;
171
23
9
Han M, Partin A W, Pound C R et al.
Long-term biochemical disease-free and cancer-specific survival following anatomic
radical retropubic prostatectomy. The 15-year Johns Hopkins experience.
Urol Clin North Am.
2001;
28
555-565
10
Heidenreich A, Aus G, Abbou C C et al.
Guidelines on Prostate Cancer.
Eur Association of Urol.
2005;
48
546-551
11
Hull G W, Rabbani F, Abbas F et al.
Cancer control with radical prostatectomy alone in 1000 consecutive patients.
J Urol.
2002;
167 (2 Pt 1)
528-534
12
Jacobsen N EB, Moore K, Estey E et al.
Open versus laparoscopic radical prostatectomy: a prospective comparison of postoperative
urinary incontinence rates.
J Urol.
2007;
177
615-619
13
Michl U HG, Friedrich M G, Graefen M et al.
Prediction of postoperative sexual function after nerve sparing radical retropubic
prostatectomy.
J Urol.
2006;
176
227-231
14
Noldus J, Michl U, Graefen M et al.
Patient-reported sexual function after nerve-sparing radical retropubic prostatectomy.
Eur Urol.
2002;
42
118
15
Ponholzer A, Brössner C, Struhal G et al.
Lower urinary tract symptoms, urinary incontinence, sexual function and quality of
life after radical prostatectomy and external beam radiation therapy: real life experience
in Austria.
World J Urol.
2006;
24
325-330
16
van Poppel H, Goethuys H, Callewaert P et al.
Radical prostatectomy can provide cure for well selected clinical stage T3 prostate
cancer.
Eur Urol.
2000;
38
372-379
17
Rosen R C, Cappelleri J C, Smith M D et al.
Development and evaluation of an abridged, 5-item version of the International Index
of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction.
Int J Impot Res.
1999;
11
319
18
Swindle P, Eastham J A, Ohori M et al.
Do margins matter? The prognostic significance of positive surgical margins in radical
prostatectomy specimens.
J Urol.
2005;
174
903-907
19
Ward J F, Slezak J M, Blute M L et al.
Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent
of prostate-specific antigen testing: 15-year outcome.
BJU Int.
2005;
95
751-756
20
Wieder J A, Soloway M S.
Incidence, etiology, location, prevention and treatment of positive surgical margins
after radical prostatectomy for prostate cancer.
J Urol.
1998;
160
299
21
Wirth M P, Hakenberg O W, Fröhner M.
Therapie des lokalen fortgeschrittenen Prostatakarzinoms.
Urologe.
2005;
44
1295-1302
Prof. Dr. T. Kälble
Klinikum Fulda gAG · Klinik für Urologie und Kinderurologie
Pacelliallee 4
36043 Fulda
Germany
eMail: t.kaelble.urologie@klinikum-fulda.de